Tatiana Codjia, Christian Hobeika, Pierre Platevoet, Riccardo Pravisani, Safi Dokmak, Béatrice Aussilhou, Lancelot Marique, Jérome Cros, François Cauchy, Mickael Lesurtel, Alain Sauvanet
BACKGROUND: The value of splenectomy for body localization (≥ 5 cm from spleen hilum) of pancreatic ductal adenocarcinoma (B-PDAC) is uncertain. This study assessed spleen-preserving distal pancreatectomy (SPDP) results for B-PDAC. PATIENTS AND METHODS: This single-center study included patients who underwent SPDP (Warshaw's technique) or distal splenopancreactomy (DSP) for B-PDAC from 2008 to 2019. Propensity score matching was performed to balance SPDP and DSP patients regarding sex, age, American Society of Anesthesiologists (ASA), body mass index (BMI), laparoscopy, pathological features [American Joint Committee on Cancer (AJCC)/tumor node metastasis classification (TNM)], margins, and neoadjuvant/adjuvant therapies...
March 25, 2024: Annals of Surgical Oncology